Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A KEITH

Showing results (811-820 of 918) with videos related to

Pageof 92
Sort By:
Clinical and Translational Gastroenterology|October 8, 2021
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing StudyPedro L S Uson, N Jewel Samadder, Douglas Riegert-Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Survival and years of life lost in different age cohorts of patients with multiple myelomaHeinz Ludwig, Vanessa Bolejack, John Crowley, et al.
JAMA Oncology|January 7, 2021
Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19Alejandro Berlin, Mike Lovas, Tran Truong, et al.
Blood|June 11, 2014
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myelomaYuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, et al.
Nature Communications|February 20, 2021
The evolution of critical thermal limits of life on EarthJoanne M Bennett, Jennifer Sunday, Piero Calosi, et al.
Cancer Research|March 3, 2004
Genetics and cytogenetics of multiple myeloma: a workshop reportRafael Fonseca, Bart Barlogie, Regis Bataille, et al.
Blood|July 27, 2016
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genesK Martin Kortüm, Elias K Mai, Nur H Hanafiah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple MyelomaA Keith Stewart, Meletios A Dimopoulos, Tamás Masszi, et al.
Mayo Clinic Proceedings|October 3, 2007
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myelomaMartha Q Lacy, Morie A Gertz, Angela Dispenzieri, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Synthesis of 7-chloro-2,3-dihydro-2-[1-(pyridinyl)alkyl]-pyridazino[4,5-b]quinoline-1,4,10(5H)-triones as NMDA glycine-site antagonistsDean G Brown, Rebecca A Urbanek, Thomas M Bare, et al.
Pageof 92

Showing results (811-820 of 918) with videos related to

Sort By:
Pageof 92
Clinical and Translational Gastroenterology|October 8, 2021
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing StudyPedro L S Uson, N Jewel Samadder, Douglas Riegert-Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Survival and years of life lost in different age cohorts of patients with multiple myelomaHeinz Ludwig, Vanessa Bolejack, John Crowley, et al.
JAMA Oncology|January 7, 2021
Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19Alejandro Berlin, Mike Lovas, Tran Truong, et al.
Blood|June 11, 2014
Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myelomaYuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, et al.
Nature Communications|February 20, 2021
The evolution of critical thermal limits of life on EarthJoanne M Bennett, Jennifer Sunday, Piero Calosi, et al.
Cancer Research|March 3, 2004
Genetics and cytogenetics of multiple myeloma: a workshop reportRafael Fonseca, Bart Barlogie, Regis Bataille, et al.
Blood|July 27, 2016
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genesK Martin Kortüm, Elias K Mai, Nur H Hanafiah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple MyelomaA Keith Stewart, Meletios A Dimopoulos, Tamás Masszi, et al.
Mayo Clinic Proceedings|October 3, 2007
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myelomaMartha Q Lacy, Morie A Gertz, Angela Dispenzieri, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
Synthesis of 7-chloro-2,3-dihydro-2-[1-(pyridinyl)alkyl]-pyridazino[4,5-b]quinoline-1,4,10(5H)-triones as NMDA glycine-site antagonistsDean G Brown, Rebecca A Urbanek, Thomas M Bare, et al.
Pageof 92